PTHL Share Price Performance
US$0.45
-3.73 (-89.32%)
Price US$0.45
Share Pricen/a
Pheton Holdings Ltd Stock Price
- 0 Narratives written by author
- 1 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
PTHL Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Pheton Holdings Ltd Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.14
- 82.86%
- -790.57%
- 2.9%
About PTHL
- Founded
- 1998
- Employees
- 10
- CEO
- WebsiteView website
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is headquartered in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.
